Overview

NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.

Eligibility

Inclusion Criteria:

• Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit.
• Scheduled for implantation of Preserflo microshunt, trabeculectomy or other types of MIGS
• Ability to cooperate fairly well during the examinations
• Willing to participate in the study and capable of providing informed consent

Exclusion Criteria:

• High intraocular pressure due to increased episcleral venous pressure, hemorrhagic glaucoma, traumatic glaucoma or uveitis glaucoma